Glucosamine & Chondroitin
Supplements · Joint Health · Supplement, Typed Supps
Cartilage building blocks, sold together for decades.
Stage by stage
- Intake (Capsule): A significant portion of chondroitin’s large molecules are broken down before reaching the bloodstream intact.
- Small intestine (Partial absorption): Absorbed in the small intestine, though a significant portion of chondroitin’s large molecules break down before reaching the bloodstream intact.
- Joint tissue (Raw material for cartilage): Used as raw material for maintaining cartilage.
- Pain relief (Mixed trial results): Large trials show mixed results for pain relief.
What the evidence supports
- Reducing osteoarthritis pain — limited evidence. The large independent trials were largely null, while many industry-funded ones were positive. Where benefit appears it is small and may be limited to more severe pain. Glucosamine sulfate has fared slightly better than hydrochloride.
- Slowing joint structural damage — insufficient evidence. Long-term imaging trials have not demonstrated it, despite this being the mechanism the product is sold on.
- Rebuilding cartilage — insufficient evidence. Not shown, and not what the biology would predict from an oral dose.
Typical dose
1500 mg glucosamine daily and 1200 mg chondroitin sulfate daily — the doses the GAIT trial used, split as 500 mg and 400 mg three times a day
Upper limit: No formal UL. Large trials at the standard 1500 mg and 1200 mg doses have not turned up major safety problems
Timing
With food, standard dosing.
Time to effect
- Wks–mo: Any reported joint comfort change, varying significantly by trial.
Medication interactions
- Warfarin: Repeated case reports of raised INR when glucosamine is added. Tell whoever manages your anticoagulation. (high)
- Diabetes medication: Older concerns about glucose control have largely not been borne out, but monitoring is sensible. (moderate)
Common myth
“Glucosamine and chondroitin reliably rebuild cartilage.” In reality: Some large trials show effects barely different from placebo — a genuinely debated combination in the research.
Relevant movements
More in Joint Health
In the glossary
Sources